Berliner Institut für Gesundheitsforschung - Charité und Max-Delbrück-Centrum

Christopher Baum chosen to head the BIH

On August 5, 2020, the Supervisory Board of the BIH, chaired by BMBF State Secretary Christian Luft, appointed Professor Christopher Baum as Chief Executive Officer of the BIH.

To the press release

Strengthening the translational vascular biomedicine

With BIH Professor Michael Potente, BIH, Charité and MDC strengthen their research focus on "Translational Vascular Biomedicine".

To the press release

HIV-1: The undercover agent

Scientists* at the BIH and the Charité found out that the AIDS virus HIV-1 goes largely unnoticed by T-cells of the immune system thanks to an ingenious propagation strategy.

To the press release

Research and clinical practice under one roof

On 20 July 2020 BIH and Charité celebrated the topping-out ceremony for the new ATIZ building together with Federal Research Minister Anja Karliczek and the Governing Mayor of Berlin, Michael Müller.

To the press release

Dangerous dual role of the immune system in COVID-19

Scientists from the BIH, Charité, Leipzig and Heidelberg found that the immune system has a decisive influence on the course of COVID-19 and sometimes overshoots the mark.

To the press release

Our mission: Translation!

The mission of the BIH is medical translation: The BIH aims to translate findings from biomedical research into new approaches for personalised prediction, prevention and therapy and, conversely, to develop new research approaches from clinical observations. The goal is always the medical benefit for patients*.

More about the mission of the BIH

BIH closed in Spreepalais - Corona research at full speed

To protect against SARS-CoV-2, the BIH works largely in the home office. Meanwhile, research on Corona/COVID-19 is in full swing.

A new Chapter for the Berlin Institute of Health

Anja Karliczek and Michael Müller signed an administrative agreement on the integration of the BIH into Charité.